Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy

Hemophilia A, a single gene disorder leading to deficient Factor VIII (FVIII), is a suitable candidate for gene therapy. The aspiration is for single administration of a genetic therapy that would allow the production of endogenous FVIII sufficient to restore hemostasis and other biological processe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pipe, Steven W., Arruda(Late), Valder R., Lange, Claudia, Kitchen, Stephen, Eichler, Hermann, Wadsworth, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Life Sciences, Genetics & Genomics, Molecular Medicine, Genetics & Heredity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186383/
https://www.ncbi.nlm.nih.gov/pubmed/36111754
http://dx.doi.org/10.2174/1566523222666220914105729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186383/
https://www.ncbi.nlm.nih.gov/pubmed/36111754
http://dx.doi.org/10.2174/1566523222666220914105729

Ejemplares similares